Your browser doesn't support javascript.
loading
Diabéticos tipo 1 portadores de síndrome metabólico: cuantificación de la resistencia a la insulina / Type 1 diabetics patients carriers of metabolic syndrome: quantification of insulin resistance
Sanhueza M., Lilian; Concha L., Luciana; Durruty A., Pilar; Rubio C., Claudia; Wolff F., Carlos; García de los Ríos A., Manuel.
  • Sanhueza M., Lilian; Hospital San Juan de Dios. Unidad de Diabetes. CL
  • Concha L., Luciana; Hospital San Juan de Dios. Unidad de Diabetes. CL
  • Durruty A., Pilar; Hospital San Juan de Dios. Unidad de Diabetes. CL
  • Rubio C., Claudia; Hospital San Juan de Dios. Unidad de Diabetes. CL
  • Wolff F., Carlos; Universidad de Chile. Facultad de Medicina. Servicio y Departamento de Medicina Occidente. Laboratorio Hepatología. CL
  • García de los Ríos A., Manuel; Hospital San Juan de Dios. Unidad de Diabetes. CL
Rev. chil. endocrinol. diabetes ; 7(3): 89-93, jul.2014. tab, graf
Article in Spanish | LILACS | ID: lil-789303
ABSTRACT
The presence of insulin resistance (IR) has been indirectly assessed in Type 1 Diabetics (T1DM) through the detection of Metabolic Syndrome (MS), by applying criteria for Type 2 Diabetics(T2DM). In the EDC study (the Pittsburg Epidemiology of Diabetes Complications) a formula applicable to T1DM was validated, quantifying IR through the glucose uptake (GU) employing the usual clinical and laboratory parameters, in patients with HbA1c < 11.4 percent. Objectives: To determine in T1DM whether there exists a relationship between the presence of MS according to the Modified NCEP/ATPIII criteria and IR quantification through assessment of the glucose uptake or GU. Patients and Method: The modified NCEP/ATPIII criteria were applied to 150 T1DM patients, and those with more than 3 altered parameters were classified as MS carriers. IR was quantified through the glucose uptake (GU), applying the formula for Estimated Glucose Disposal Rate (GDR-EDC). Results: 26.6 percent of the T1DM (40 patients) complied with the modified NCEP/ATPIII criteria. When the formula for GU was applied (31 patient), 90.3 percent of the T1DM showed insulin resistance (GU value < 8.77). And when applied to 124 patients (T1DM with and without MS and HbA1c < 11,4 percent) 75 percent showed IR...
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Insulin Resistance / Metabolic Syndrome / Diabetes Mellitus, Type 1 Type of study: Observational study / Prevalence study / Risk factors Limits: Adult / Female / Humans / Male Language: Spanish Journal: Rev. chil. endocrinol. diabetes Journal subject: Endocrinology Year: 2014 Type: Article Affiliation country: Chile Institution/Affiliation country: Hospital San Juan de Dios/CL / Universidad de Chile/CL

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Insulin Resistance / Metabolic Syndrome / Diabetes Mellitus, Type 1 Type of study: Observational study / Prevalence study / Risk factors Limits: Adult / Female / Humans / Male Language: Spanish Journal: Rev. chil. endocrinol. diabetes Journal subject: Endocrinology Year: 2014 Type: Article Affiliation country: Chile Institution/Affiliation country: Hospital San Juan de Dios/CL / Universidad de Chile/CL